Protection of stromal cell-derived factor 2 by heat shock protein 72 prevents oxaliplatin-induced cell death in oxaliplatin-resistant human gastric cancer cells

Katsuyuki Takahashi, Masako Tanaka, Masakazu Yashiro, Masaki Matsumoto, Asuka Ohtsuka, Keiichi I. Nakayama, Yasukatsu Izumi, Katsuya Nagayama, Katsuyuki Miura, Hiroshi Iwao, Masayuki Shiota

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Heat shock protein 72 (Hsp72) is a molecular chaperone that assists in the folding of nascent polypeptides and in the refolding of denatured proteins. In many cancers, Hsp72 is constitutively expressed at elevated levels, which can result in enhanced stress tolerance. Similarly, following treatment with anticancer drugs, Hsp72 binds to denatured proteins that may be essential for survival. We therefore hypothesized that Hsp72 client proteins may play a crucial role in drug resistance. Here, we aimed to identify proteins that are critical for oxaliplatin (OXA) resistance by analyzing human gastric cancer cell lines, as well as OXA-resistant cells via a mass spectrometry-based proteomic approach combined with affinity purification using anti-Hsp72 antibodies. Stromal cell-derived factor 2 (SDF-2) was identified as an Hsp72 client protein unique to OCUM-2M/OXA cells. SDF-2 was overexpressed in OXA-resistant cells and SDF-2 silencing promoted the apoptotic effects of OXA. Furthermore, Hsp72 prevented SDF-2 degradation in a chaperone activity-dependent manner. Together, our data demonstrate that Hsp72 protected SDF-2 to avoid OXA-induced cell death. We propose that inhibition of SDF-2 may comprise a novel therapeutic strategy to counteract OXA-resistant cancers.

Original languageEnglish
Pages (from-to)8-15
Number of pages8
JournalCancer Letters
Volume378
Issue number1
DOIs
Publication statusPublished - 2016 Aug 1
Externally publishedYes

Fingerprint

oxaliplatin
HSP72 Heat-Shock Proteins
Stromal Cells
Stomach Neoplasms
Cell Death
Proteins
Protein Refolding
Molecular Chaperones
Drug Resistance

Keywords

  • Drug resistance
  • Heat shock protein 72
  • Oxaliplatin

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Protection of stromal cell-derived factor 2 by heat shock protein 72 prevents oxaliplatin-induced cell death in oxaliplatin-resistant human gastric cancer cells. / Takahashi, Katsuyuki; Tanaka, Masako; Yashiro, Masakazu; Matsumoto, Masaki; Ohtsuka, Asuka; Nakayama, Keiichi I.; Izumi, Yasukatsu; Nagayama, Katsuya; Miura, Katsuyuki; Iwao, Hiroshi; Shiota, Masayuki.

In: Cancer Letters, Vol. 378, No. 1, 01.08.2016, p. 8-15.

Research output: Contribution to journalArticle

Takahashi, K, Tanaka, M, Yashiro, M, Matsumoto, M, Ohtsuka, A, Nakayama, KI, Izumi, Y, Nagayama, K, Miura, K, Iwao, H & Shiota, M 2016, 'Protection of stromal cell-derived factor 2 by heat shock protein 72 prevents oxaliplatin-induced cell death in oxaliplatin-resistant human gastric cancer cells', Cancer Letters, vol. 378, no. 1, pp. 8-15. https://doi.org/10.1016/j.canlet.2016.05.002
Takahashi, Katsuyuki ; Tanaka, Masako ; Yashiro, Masakazu ; Matsumoto, Masaki ; Ohtsuka, Asuka ; Nakayama, Keiichi I. ; Izumi, Yasukatsu ; Nagayama, Katsuya ; Miura, Katsuyuki ; Iwao, Hiroshi ; Shiota, Masayuki. / Protection of stromal cell-derived factor 2 by heat shock protein 72 prevents oxaliplatin-induced cell death in oxaliplatin-resistant human gastric cancer cells. In: Cancer Letters. 2016 ; Vol. 378, No. 1. pp. 8-15.
@article{9e96ba1c298b4adb95ef6c8747367fe2,
title = "Protection of stromal cell-derived factor 2 by heat shock protein 72 prevents oxaliplatin-induced cell death in oxaliplatin-resistant human gastric cancer cells",
abstract = "Heat shock protein 72 (Hsp72) is a molecular chaperone that assists in the folding of nascent polypeptides and in the refolding of denatured proteins. In many cancers, Hsp72 is constitutively expressed at elevated levels, which can result in enhanced stress tolerance. Similarly, following treatment with anticancer drugs, Hsp72 binds to denatured proteins that may be essential for survival. We therefore hypothesized that Hsp72 client proteins may play a crucial role in drug resistance. Here, we aimed to identify proteins that are critical for oxaliplatin (OXA) resistance by analyzing human gastric cancer cell lines, as well as OXA-resistant cells via a mass spectrometry-based proteomic approach combined with affinity purification using anti-Hsp72 antibodies. Stromal cell-derived factor 2 (SDF-2) was identified as an Hsp72 client protein unique to OCUM-2M/OXA cells. SDF-2 was overexpressed in OXA-resistant cells and SDF-2 silencing promoted the apoptotic effects of OXA. Furthermore, Hsp72 prevented SDF-2 degradation in a chaperone activity-dependent manner. Together, our data demonstrate that Hsp72 protected SDF-2 to avoid OXA-induced cell death. We propose that inhibition of SDF-2 may comprise a novel therapeutic strategy to counteract OXA-resistant cancers.",
keywords = "Drug resistance, Heat shock protein 72, Oxaliplatin",
author = "Katsuyuki Takahashi and Masako Tanaka and Masakazu Yashiro and Masaki Matsumoto and Asuka Ohtsuka and Nakayama, {Keiichi I.} and Yasukatsu Izumi and Katsuya Nagayama and Katsuyuki Miura and Hiroshi Iwao and Masayuki Shiota",
year = "2016",
month = "8",
day = "1",
doi = "10.1016/j.canlet.2016.05.002",
language = "English",
volume = "378",
pages = "8--15",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Protection of stromal cell-derived factor 2 by heat shock protein 72 prevents oxaliplatin-induced cell death in oxaliplatin-resistant human gastric cancer cells

AU - Takahashi, Katsuyuki

AU - Tanaka, Masako

AU - Yashiro, Masakazu

AU - Matsumoto, Masaki

AU - Ohtsuka, Asuka

AU - Nakayama, Keiichi I.

AU - Izumi, Yasukatsu

AU - Nagayama, Katsuya

AU - Miura, Katsuyuki

AU - Iwao, Hiroshi

AU - Shiota, Masayuki

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Heat shock protein 72 (Hsp72) is a molecular chaperone that assists in the folding of nascent polypeptides and in the refolding of denatured proteins. In many cancers, Hsp72 is constitutively expressed at elevated levels, which can result in enhanced stress tolerance. Similarly, following treatment with anticancer drugs, Hsp72 binds to denatured proteins that may be essential for survival. We therefore hypothesized that Hsp72 client proteins may play a crucial role in drug resistance. Here, we aimed to identify proteins that are critical for oxaliplatin (OXA) resistance by analyzing human gastric cancer cell lines, as well as OXA-resistant cells via a mass spectrometry-based proteomic approach combined with affinity purification using anti-Hsp72 antibodies. Stromal cell-derived factor 2 (SDF-2) was identified as an Hsp72 client protein unique to OCUM-2M/OXA cells. SDF-2 was overexpressed in OXA-resistant cells and SDF-2 silencing promoted the apoptotic effects of OXA. Furthermore, Hsp72 prevented SDF-2 degradation in a chaperone activity-dependent manner. Together, our data demonstrate that Hsp72 protected SDF-2 to avoid OXA-induced cell death. We propose that inhibition of SDF-2 may comprise a novel therapeutic strategy to counteract OXA-resistant cancers.

AB - Heat shock protein 72 (Hsp72) is a molecular chaperone that assists in the folding of nascent polypeptides and in the refolding of denatured proteins. In many cancers, Hsp72 is constitutively expressed at elevated levels, which can result in enhanced stress tolerance. Similarly, following treatment with anticancer drugs, Hsp72 binds to denatured proteins that may be essential for survival. We therefore hypothesized that Hsp72 client proteins may play a crucial role in drug resistance. Here, we aimed to identify proteins that are critical for oxaliplatin (OXA) resistance by analyzing human gastric cancer cell lines, as well as OXA-resistant cells via a mass spectrometry-based proteomic approach combined with affinity purification using anti-Hsp72 antibodies. Stromal cell-derived factor 2 (SDF-2) was identified as an Hsp72 client protein unique to OCUM-2M/OXA cells. SDF-2 was overexpressed in OXA-resistant cells and SDF-2 silencing promoted the apoptotic effects of OXA. Furthermore, Hsp72 prevented SDF-2 degradation in a chaperone activity-dependent manner. Together, our data demonstrate that Hsp72 protected SDF-2 to avoid OXA-induced cell death. We propose that inhibition of SDF-2 may comprise a novel therapeutic strategy to counteract OXA-resistant cancers.

KW - Drug resistance

KW - Heat shock protein 72

KW - Oxaliplatin

UR - http://www.scopus.com/inward/record.url?scp=84966348774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84966348774&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2016.05.002

DO - 10.1016/j.canlet.2016.05.002

M3 - Article

VL - 378

SP - 8

EP - 15

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 1

ER -